文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Guido Cefarelli
发表
First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study
M. Rizzo, A. Sola, M. Chacón, 2022, World journal of clinical oncology.
Cisplatin, Docetaxel and Cetuximab (TPEx) as First-line Treatment for Patients With Recurrent or Metastatic Head and Neck Cancer: A Multicenter Real-World Study
M. Rizzo, A. Sola, M. Chacón, 2020 .